Understanding the Clinical Priority
In the setting of an acute ST-segment elevation myocardial infarction (STEMI) requiring emergent percutaneous coronary intervention (PCI), the nurse must rapidly prioritize interventions that directly enable the procedure and prevent catastrophic delays. The ECG findings of ST-segment elevation in leads II, III, and aVF indicate an inferior wall MI, often involving the right coronary artery. This is a time-sensitive emergency where "door-to-balloon" time directly correlates with myocardial salvage and survival.
Analysis of the Correct Answer
The priority action is to
verify that informed consent has been obtained and assess for allergies. According to the SCAI Expert Consensus Statement on best practices in the cardiac catheterization laboratory, a foundational pre-procedure requirement is ensuring proper documentation, which includes a signed informed consent and a documented allergy assessment
[2]. Without a verified consent, the procedure cannot legally or ethically proceed, causing a critical delay in reperfusion. Simultaneously, identifying allergies—particularly to contrast dye, aspirin, or P2Y12 inhibitors like clopidogrel—is essential for the interventional cardiologist to plan the procedure safely and select appropriate pharmacotherapy during and after stent placement. This dual check is a safety hard stop that must occur before the patient is transported to the catheterization laboratory.
Why Other Options Are Not the Priority
-
Option 1 (Administer prescribed anxiolytic): While managing anxiety is a component of holistic nursing care, administering a sedative is not the immediate pre-procedural priority. The SCAI guidelines emphasize that the pre-procedure phase is focused on safety checks, clinical optimization, and communication, not routine sedation
[2]. Anxiolysis may be considered later but does not take precedence over legal and safety prerequisites for the procedure.
-
Option 2 (Obtain baseline vital signs and complete a focused cardiovascular assessment): A focused assessment is a critical nursing function and should be performed concurrently. However, in the specific sequence of preparing for an emergent PCI, the verification of consent and allergies is a more immediate, non-delegable task that directly gates the procedure's initiation. The assessment can be completed while other team members prepare the patient, but a missing consent stops all forward momentum.
-
Option 3 (Ensure the patient has been NPO for at least 8 hours): The requirement for a strict 8-hour NPO status is not an absolute contraindication for emergent PCI. In the context of a STEMI, the benefits of rapid revascularization far outweigh the aspiration risks associated with a non-empty stomach. The SCAI best practices document addresses the management of urgent and emergent procedures, where standard fasting protocols are modified based on clinical necessity
[2]. The team will proceed with the procedure using appropriate precautions, making this a lower priority than securing consent and identifying a potentially fatal allergy.
Clinical Reasoning and Safety Integration
The core principle here is the establishment of a safe and legally sound environment for an invasive procedure. The SCAI consensus statement highlights that the cardiac catheterization laboratory is a high-throughput setting where optimal periprocedural communication and documentation are paramount to patient safety
[2]. A verified informed consent confirms the patient's or surrogate's understanding and agreement, while a documented allergy assessment prevents iatrogenic harm from anaphylaxis or acute kidney injury. These two elements form a critical safety barrier that must be confirmed before the patient leaves the emergency department for the catheterization laboratory.
References (research sources)
- [2]
SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Association of interventional cardiology–Association canadienne de cardiologie d'intervention)*GuidelineSrihari S. Naidu, Herbert D. Aronow, Lyndon C. Box, Peter L. Duffy, Daniel M. Kolansky, Joel M. Kupfer (2016) · DOI: 10.1002/ccd.26551